Related Experiment Video
Updated: Mar 21, 2026
![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)
Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol
Published on: September 21, 2021
Tryptophan Metabolism in Allergic Disorders
Johanna M Gostner1, Katrin Becker, Heinz Kofler
1Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Elevated tryptophan levels in allergic disease patients outside pollen season may stem from nitric oxide suppressing indoleamine 2,3-dioxygenase-1 (IDO-1). This suggests IDO-1 inhibition could be a therapeutic target.
Area of Science:
- Immunology
- Allergy Research
- Tryptophan Metabolism
Background:
- Allergic diseases like asthma and rhinitis feature a Th2-skewed immune response with upregulated Th2 cytokines and downregulated Th1 cytokines, including interferon-gamma (IFN-γ).
- IFN-γ induces indoleamine 2,3-dioxygenase-1 (IDO-1), an enzyme that degrades tryptophan, impacting T cell proliferation and immune regulation.
- Elevated serum tryptophan and a minor change in the kynurenine/tryptophan ratio (Kyn/Trp) have been observed in pollen allergy patients, particularly outside the pollen season.
Purpose of the Study:
- To investigate the reasons for higher tryptophan concentrations in pollen allergy patients outside the pollen season.
- To explore the role of nitric oxide (NO∙) and its interaction with IDO-1 in regulating tryptophan levels in allergic conditions.
- To assess the potential of targeting IDO-1 or NO∙ production for antiallergic therapies.
Main Methods:
- Review of existing literature on allergic inflammation, immune responses, and tryptophan metabolism.
- Analysis of reported associations between tryptophan levels, pollen allergy, and immunotherapy response.
- Consideration of the interplay between nitric oxide (NO∙) and indoleamine 2,3-dioxygenase-1 (IDO-1) activity.
Main Results:
- Increased tryptophan concentrations are found in pollen allergy patients outside the pollen season, not during.
- Nitric oxide (NO∙) has been reported to be elevated in asthma and allergic rhinitis patients.
- NO∙ suppresses the activity of the tryptophan-degrading enzyme IDO-1, potentially explaining higher tryptophan levels.
Conclusions:
- The suppression of IDO-1 by NO∙ may explain elevated tryptophan levels in allergic patients outside the pollen season.
- Inhibitors of inducible NO∙ synthase could be reconsidered for out-of-season antiallergic therapy by reducing NO∙ production and thus IDO-1 inhibition.
- Tryptophan metabolism is a relevant factor in the pathophysiology of allergic disorders and warrants further investigation.
More Related Videos
09:31PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
Published on: September 26, 2020
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
Related Concept Videos
Amino Acid Biosynthetic Pathways
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Repressible Operon: trp Operon